Are you Dr. Idell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11937 Us Highway 271
Tyler, TX 75708Phone+1 903-877-7777Fax+1 903-877-5838
Summary
- Dr. Steven Idell, MD is a pulmonologist in Tyler, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with UT Health North Campus Tyler.
Education & Training
- Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1983
- Temple University HospitalResidency, Internal Medicine, 1977 - 1980
- Lewis Katz School of Medicine at Temple UniversityClass of 1977
Certifications & Licensure
- TX State Medical License 1985 - 2025
- PA State Medical License 1979 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 18 citationsPhage Display-Derived Peptide for the Specific Binding of SARS-CoV-2.Fan Yang, Li Liu, Pierre Fernand Neuenschwander, Steven Idell, Ramakrishna Vankayalapati
ACS Omega. 2022-02-01 - 280 citationsCoagulation, fibrinolysis, and fibrin deposition in acute lung injury.Steven Idell
Critical Care Medicine. 2003-04-01 - 29 citationsPD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways.Xia Guo, Christudas Sunil, Oluwaseun Adeyanju, Andrew Parker, Steven Huang
Scientific Reports. 2022-02-23
Press Mentions
- Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19September 9th, 2020
- East Texas Researchers Studying More Effective Treatments for Cancer, Other Incurable DiseasesJanuary 30th, 2020
- UTHSC: $1.4 Million Grant Renewal to Inspire Tuberculosis Research at Tyler Research CenterNovember 5th, 2019
- Join now to see all
Grant Support
- PAI-1 Targeted Intrapleural Fibronolytic TherapyNational Heart, Lung, And Blood Institute2011
- Fibrinolytic Pathways In Lung Injury And RepairNational Heart, Lung, And Blood Institute2005–2009
- Control Of Fibrin Turnover In Pleural DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Administrative CoreNational Heart, Lung, And Blood Institute2005
- Control Of Fibrin Turnover In Pleural DiseaseNational Heart, Lung, And Blood Institute1991–2004
- Molecular Biology And Physiology Of Human Factor VIINational Heart, Lung, And Blood Institute1990–1992
- Lung Lavage Procoagulants In Lung Injury And RepairNational Heart, Lung, And Blood Institute1986–1990